SI - NYSE

Shoulder Innovations, Inc.

SI·NYSE

$14.00

-1.2%

HealthcareMedical - Specialties

Shoulder Innovations, Inc. manufactures medical devices. It has developed a shoulder replacement system. The company was founded by Stephen B. Gunther and Michael DeVries in 2009 and is headquartered in Grand Rapids, MI.

Statements Value Model

At a Glance

Live Snapshot

Market Cap$290.34M

EPS-0.0047

P/E Ratio-3073.07

Earnings Date07/24/2026

si

Total Current Assets

Last Annual Value

157.16M

3-Year CAGR

49%

5-Year CAGR

27%

10-Year CAGR

13%

Adjust for Inflation

Shoulder Innovations, Inc. Competitors Analysis of Total Current Assets

SI · NYSE

Company	Total Current Assets	CAGR 3Y	CAGR 5Y	CAGR 10Y
Shoulder Innovations, Inc. NYSE:SI	157.16M	48.6%	N/A	N/A
CVRx, Inc. NASDAQ:CVRX	101.65M	-3.2%	-7.6%	N/A
Lifecore Biomedical, Inc. NASDAQ:LFCR	85.68M	-3.0%	-10.4%	-0.1%
NeoGenomics, Inc. NASDAQ:NEO	376.29M	-14.3%	-11.2%	16.9%
Quanterix Corporation NASDAQ:QTRX	212.26M	-17.8%	-13.9%	19.7%
Exagen Inc. NASDAQ:XGN	48.89M	0.7%	-15.4%	N/A
Enanta Pharmaceuticals, Inc. NASDAQ:ENTA	204.34M	-21.5%	-8.5%	-1.3%
Nautilus Biotechnology, Inc. NASDAQ:NAUT	105.96M	-15.7%	-21.2%	N/A
Aardvark Therapeutics, Inc. Common Stock NASDAQ:AARD	111.89M	121.0%	N/A	N/A
Assembly Biosciences, Inc. NASDAQ:ASMB	254.55M	23.9%	10.5%	16.9%
Outset Medical, Inc. NASDAQ:OM	250.88M	-4.8%	-9.3%	N/A

Shoulder Innovations, Inc. Fair Value Envelope

SI · NYSE

Our analysis suggests that SI has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $14, this represents a potential HIDDEN relative to our calculated worth for Shoulder Innovations, Inc..

HIDDEN

Intrinsic Value

Current Price: $14

Related Guides

Blog Categories

Continue your SI research with focused valuation guides.

Fundamentals

Decode statement quality and operating durability.

Accounting

Interpret line items with cleaner analytical framing.

Forecasting

Translate historical performance into forward scenarios.

Reference

Use practical frameworks for statement-led valuation.

Research Paths

Pick your next lens

Snapshot

Start with context, operating signals, and key market metrics.

Value Model

Stress test fair value across bear, base, and bull assumptions.

Statements

Validate revenue quality, margins, and balance sheet durability.

Earnings Call

Read management commentary and compare it with reported outcomes.

Dividends

Check payout sustainability and long-term distribution behavior.

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.